Document is current
Any future updates will be listed below
-
Authors
Zhai, T. -S. https://orcid.org/0000-0002-1441-6256
Hu, L. -T.
Ma, W. -G.
Chen, X.
Luo, M.
Jin, L.
Zhou, Z.
Liu, X.
Kang, Y.
Kang, Y. -X.
Zhang, J. -X.
Liu, H.
Lu, J. -Y.
Yao, X. -D.
Ye, L.
-
Funding
Funding for this research was provided by:
National Natural Science Foundation of China (81672549)
National Natural Science Foundation of China (81972409)
Natural Science Foundation of Shanghai (15ZR1433000)
Natural Science Foundation of Shanghai (17ZR1421800)
Karamay Municipal Science and Technology Foundation (JK2017-5)
Youth Subject of Karamay Central Hospital (QK2017-5)
Health System Independent Innovation Science Foundation of Shanghai Putuo District (ptkwws201819)
- License Information
-
More Information
Article History
Received: 19 March 2020
Accepted: 7 May 2020
First Online: 30 May 2020
Compliance with ethical standards
:
: Shanghai Tenth People’s Hospital, Tongji University School of Medicine has a pending patent for using PPAT measurements as diagnostic and prognostic biomarkers of prostate cancer in patients.
: Ethical approval was obtained from Human Research Ethics Committee, Shanghai Tenth People’s Hospital, Tongji University School of Medicine and the approval number is 2019-K-135.
: Written informed consent for participation was obtained from each study participant.
